- Home
- SJM vs MRNA Comparison
SJM vs MRNA Comparison
Compare SJM & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJM
- MRNA
- Stock Information
- Founded
- SJM 1897
- MRNA 2010
- Country
- SJM United States
- MRNA United States
- Employees
- SJM N/A
- MRNA N/A
- Industry
- SJM Packaged Foods
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SJM Consumer Staples
- MRNA Health Care
- Exchange
- SJM Nasdaq
- MRNA Nasdaq
- Market Cap
- SJM 11.2B
- MRNA 9.2B
- IPO Year
- SJM N/A
- MRNA 2018
- Fundamental
- Price
- SJM $109.25
- MRNA $24.62
- Analyst Decision
- SJM Buy
- MRNA Hold
- Analyst Count
- SJM 12
- MRNA 15
- Target Price
- SJM $118.27
- MRNA $36.69
- AVG Volume (30 Days)
- SJM 1.6M
- MRNA 12.2M
- Earning Date
- SJM 11-25-2025
- MRNA 11-06-2025
- Dividend Yield
- SJM 4.03%
- MRNA N/A
- EPS Growth
- SJM N/A
- MRNA N/A
- EPS
- SJM N/A
- MRNA N/A
- Revenue
- SJM $8,714,300,000.00
- MRNA $2,232,000,000.00
- Revenue This Year
- SJM $5.00
- MRNA N/A
- Revenue Next Year
- SJM $2.20
- MRNA $10.38
- P/E Ratio
- SJM N/A
- MRNA N/A
- Revenue Growth
- SJM 2.54
- MRNA N/A
- 52 Week Low
- SJM $93.30
- MRNA $23.04
- 52 Week High
- SJM $125.42
- MRNA $48.92
- Technical
- Relative Strength Index (RSI)
- SJM 60.55
- MRNA 45.38
- Support Level
- SJM $104.63
- MRNA $23.04
- Resistance Level
- SJM $112.36
- MRNA $27.10
- Average True Range (ATR)
- SJM 2.24
- MRNA 1.61
- MACD
- SJM 0.82
- MRNA -0.02
- Stochastic Oscillator
- SJM 73.15
- MRNA 26.54
About SJM The J.M. Smucker Company
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.